CIRM grants $42m to Sangamo and stem cell researchers
This article was originally published in Scrip
Executive Summary
The California Institute for Regenerative Medicine (CIRM) gave out $42 million in grants designed to recruit stem cell researchers to the state and back human clinical trials, including a Phase I trial for Sangamo BioSciences's beta-thalassemia therapy.